Eric Swayze is VP at IONIS PHARMACEUTICALS INC (IONS). They have made 12 open-market trades across 1 company since 2021, most recently 2026-06-25.
CIK 0001791058
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IONS | 21,759 | $934K |
Shares reported on the most recent Form 4, priced at the 2026-06-26 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IONS | SELL · 10b5-1 | 2026-06-25 | 2026-06-26 | $79.18 | $839K | -20.8% | -31.1% | -46.1% |
| IONS | SELL · 10b5-1 | 2026-02-13 | 2026-02-13 | $81.76 | $1.3M | +0.4% | -9.9% | -5.8% |
| IONS | SELL | 2026-01-30 | 2026-02-02 | $82.93 | $512K | -1.5% | -4.3% | -9.1% |
| IONS | SELL | 2026-01-16 | 2026-01-20 | $75.34 | $748K | +7.2% | +7.9% | -2.9% |
| IONS | SELL · 10b5-1 | 2026-01-02 | 2026-01-06 | $79.12 | $1.9M | -7.5% | +1.2% | -9.9% |
| IONS | SELL | 2025-10-16 | 2025-10-16 | $73.62 | $4K | +0.8% | +0.4% | +8.1% |
| IONS | SELL · 10b5-1 | 2025-10-06 | 2025-10-08 | $69.02 | $945K | +4.8% | +4.8% | +16.1% |
| IONS | SELL · 10b5-1 | 2025-10-01 | 2025-10-02 | $66.16 | $3.6M | +4.4% | +7.8% | +15.8% |
| IONS | SELL · 10b5-1 | 2025-09-02 | 2025-09-04 | $50.04 | $614K | +3.2% | +16.1% | +37.7% |
| IONS | SELL | 2025-01-31 | 2025-02-03 | $32.31 | $44K | -5.0% | +5.6% | +5.3% |
| IONS | SELL | 2025-01-16 | 2025-01-17 | $32.84 | $471K | +5.4% | +1.0% | -10.2% |
| IONS | SELL · 10b5-1 | 2024-11-12 | 2024-11-14 | $37.92 | $45K | -5.0% | +2.3% | -17.2% |
| IONS | SELL | 2024-10-16 | 2024-10-17 | $38.31 | $2K | +3.0% | -12.5% | -13.9% |
| IONS | SELL | 2024-02-02 | 2024-09-04 | $49.56 | $192K | -14.7% | -20.5% | -24.9% |
| IONS | SELL | 2024-01-31 | 2024-02-02 | $51.63 | $655K | -0.7% | -9.2% | -12.8% |
| IONS | SELL | 2024-01-17 | 2024-01-18 | $50.42 | $635K | +3.2% | -11.8% | -18.7% |
| IONS | SELL · 10b5-1 | 2023-12-28 | 2024-01-02 | $50.19 | $1.4M | +2.0% | -2.9% | -16.3% |
| IONS | SELL | 2023-10-17 | 2023-10-18 | $47.95 | $2K | -4.6% | +6.2% | +10.6% |
| IONS | SELL | 2023-02-06 | 2023-02-07 | $40.79 | $148K | -5.2% | -14.6% | -13.6% |
| IONS | SELL | 2023-01-18 | 2023-01-19 | $39.74 | $448K | -1.9% | -6.0% | -9.6% |
| IONS | SELL · 10b5-1 | 2022-09-08 | 2022-09-12 | $44.55 | $20K | -4.7% | -2.5% | -18.9% |
| IONS | SELL · 10b5-1 | 2022-08-05 | 2022-08-09 | $45.20 | $45 | -1.6% | -1.0% | -7.0% |
| IONS | SELL · 10b5-1 | 2022-04-21 | 2022-04-25 | $44.15 | $17K | -10.0% | -12.8% | -9.4% |
| IONS | SELL · 10b5-1 | 2021-01-05 | 2021-01-06 | $55.99 | $11K | +7.7% | +6.2% | -16.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.